Narrow Your Results
Narrow Your Results

Content

Programs & Webcasts

On-Demand

Publications

Faculty/Authors

News/Blogs

CLE and Other Credit Types

CLE  

Search Programs

CLE Jurisdictions

CPD  

CFE-CPE (Fraud)  

Privacy CPE (IAPP)  

Search for programs by jurisdiction or CLE credit type:

 
 
  Not all credit types are available in all jurisdictions. If you choose multiple states and multiple credit types, you may end up with 0 results.  
 



 

   
      

Search for Programs with CPD Credits in:


   

   


List View Table View

Introduction to the Patent Office Exam

On-Demand Web Programs  On-Demand Web Programs    

Released on: Sep. 1, 2015

Introduction to the Patent Office Exam

Breakout: Prosecution - USPTO Guidelines and PTAB Decisions for Chemical, Pharma and Bio Patents

MP3 Audio  Audio Download (MP3)    MP4 - Mobile Video Seg  Video Download (MP4)    

Recorded on: Apr. 28, 2017

Taken from the Web Program Recorded April 27 - 28, 2017 in San FranciscoBreakout: Prosecution - USPTO Guidelines and PTAB Decisions for Chemical, Pharma and Bio Patents [01:00:28]USPTO Guidelines and PTAB Decisions for Chemical, Pharma and Bio Patents • Cased Studies of Recent PTAB Trials and Related Appeals • Helpful Hints on How to Present a Case in a PTAB Trial • Recent ex parte PTAB Decisions • Summary ...

Mock Deal Negotiation of a Patent License: A Panel of Patent Licensing Specialists

MP3 Audio  Audio Download (MP3)    MP4 - Mobile Video Seg  Video Download (MP4)    

Recorded on: Sep. 28, 2017

Taken from the Web Program Recorded September 27, 2017 in San FranciscoMock Deal Negotiation of a Patent License: A Panel of Patent Licensing Specialists [01:24:32]• Structuring the license grant • What happens when licensed products are made in one country and sold elsewhere (patent coverage, royalty base, tracking, etc.)? • Royalty, reporting, and other economic considerations • Reps and warranties and/or ...

Contractual Limits on IP Licensees and Customers

MP3 Audio  Audio Download (MP3)    MP4 - Mobile Video Seg  Video Download (MP4)    

Recorded on: Oct. 4, 2017

Taken from the Web Program Recorded October 2 - 3, 2017 in New YorkContractual Limits on IP Licensees and Customers [01:01:48] Patent Exhaustion Doctrine Copyright First Sale Doctrine Does antitrust law play a role in patent exhaustion? Drafting licenses to avoid exhaustion Impression Products v. Lexmark case What is left of Mallinckrodt and Fuji Film? The purchase price of this Web Program segment includes the following ...

Developments in Pharmaceutical and Biotech Patent Law 2017

On-Demand Web Programs  On-Demand Web Programs    Web Segment  Web Segment    MP3 Audio  Audio Download (MP3)    MP4 - Mobile Video Seg  Video Download (MP4)    

From the program: Developments in Pharmaceutical and Biotech Patent Law 2017

Released on: Nov. 6, 2017

Technological innovation, Federal Circuit appellate oversight, and Supreme Court decisions continue to drive significant changes in the law. In this program, several different perspectives on many of the most pressing issues will be offered by experienced practitioners. It is designed to give you the information you need to maintain your practice edge, concentrating on new developments from 2016 and 2017 and placing them in the context of constantly ...

Antibody Patents: Obviousness, Written Description, Enablement and Other Challenges

Transcripts  Transcripts    

Recorded on: Nov. 2, 2017

DANIEL L REISNER: Good morning, everyone. Today's topic is all about antibodies. It's going to focus on [? (1) (12) ?] issues written description, and enablement, although we'll discuss a little bit the relationship between those defenses and obviousness. So what is an antibody? It sounds like, from a survey, that a lot of you know about antibodies. So I'll make it brief. Antibodies are y-shaped multi-chained proteins. They're produced by the immune ...

Biosimilars Litigation at the Supreme Court, Federal Circuit, and District Court Levels

Transcripts  Transcripts    

Recorded on: Nov. 2, 2017

DAVID K. BARR: I've spoken on biosimilars several times in this program. And when I first spoke on it, it was before any biosimilar application had been filed, and certainly before there had been any litigation. And some of the comments were, well, why are we really focusing on this? Why are we spending time on this? The thinking was, well, a lot of the companies that are thinking of doing follow on biosimilars to the previously-approved biologics, ...

The Evolving Law of Section 101 and Life Sciences Patents

Transcripts  Transcripts    

Recorded on: Nov. 2, 2017

DAVID BARR: Welcome back, everyone, from the break for our last segment. And batting cleanup here is Jennifer Gordon, who's with Paul, Weiss, Rifkind, Wharton, and Garrison. And I've known Jennifer for a long time. And she's a great speaker, and I think this will be a wonderful last segment for our program. Jennifer is skilled in life sciences-related patent law. She has extensive experience in complex patent litigation involving biotechnology, pharmaceutical, ...

Strategic Approaches to the Interplay Between Hatch-Waxman Litigation and Inter Partes Review

Transcripts  Transcripts    

Recorded on: Nov. 2, 2017

DAVID BARR: OK, our next speaker is Benjamin Hsing. Ben is a partner at Baker & Hostetler. He's a patent litigator possessing experience with a range of technologies and focuses his practice on the enforcement of patent rights and life sciences industry with a concentration in Hatch-Waxman based litigations. Ben is an accomplished trial lawyer, having tried numerous high profile cases on behalf of major pharmaceutical and technology companies. As ...

The Changing Scope of Prior Art: What’s New, What’s In, What’s Out

Transcripts  Transcripts    

Recorded on: Nov. 2, 2017

DAVID K. BARR: Welcome back from your lunch break, everyone. Our next speaker is Ken Sonnenfeld. Ken specializes in intellectual property, particularly in the field of biotechnology and pharmaceutical law, and practices as a partner at King & Spalding. Ken represents multinational corporations and startup companies and related IP matters. With nearly 30 years of experience in IP law and a doctorate in pharmacology, Ken represents biotechnology and ...

Ethical Issues Confronting Life Sciences Patent Lawyers

Transcripts  Transcripts    

Recorded on: Nov. 2, 2017

DAVID K. BARR: Welcome back, everyone, from the break. So our next segment is the all important ethics segment. It gives you your ethics credit. But more importantly, we have a great speaker today. Sanjay Murthy's going to be speaking on ethical issues confronting our practice, life sciences patent lawyers. So Sanjay is a partner in the Intellectual Property Group in the Chicago office of Morgan Lewis and Bockius, and he has over 15 years of patent ...

Trade Secrets 2017: What Every IP Attorney Should Know -- Winning Trade Secrets Cases as a Plaintiff and a Defendant, and Preventing Litigation Altogether

Web Segment  Web Segment    MP3 Audio  Audio Download (MP3)    MP4 - Mobile Video Seg  Video Download (MP4)    

From the program: Trade Secrets 2017: What Every IP Attorney Should Know

Recorded on: Nov. 10, 2017

Taken from the Web Program Trade Secrets 2017: What Every Lawyer Should Know recorded November 2017 Winning Trade Secrets Cases as a Plaintiff and a Defendant, and Preventing Litigation Altogether [00:58:40] Pre-suit investigation: what do you need to know right from the start, and how will you learn it? Avoiding suing too early or too late Proving reasonable measures to protect trade secrets: common pitfalls Ethical ...

Understanding the Intellectual Property License 2017

On-Demand Web Programs  On-Demand Web Programs    Web Segment  Web Segment    MP3 Audio  Audio Download (MP3)    MP4 - Mobile Video Seg  Video Download (MP4)    

From the program: Understanding the Intellectual Property License 2017

Released on: Nov. 14, 2017

Companies continue turning to licensing because it offers valuable economic and strategic opportunities.  Licensing can be used to gain access to intellectual property at a lower cost than developing or purchasing intellectual property assets, and as a way of generating new sources of revenue out of existing intellectual property assets.  Virtually every business today must confront licensing issues and, therefore, a solid base of knowledge ...

Patent and Technology Licensing

Transcripts  Transcripts    

Recorded on: Nov. 10, 2017

SUSAN PROGOFF: Welcome back. I hope everybody had a good lunch. We're going to pick up with patent and technology licensing. Kristin Neuman is our next speaker, and she's the executive director of biotechnology licensing at MPEG LA, LLC, which is the world's leader in the management of patent pools and other collaborative licensing programs. Kristin leads the MPEG initiative to form a patent pool for the gene editing technology known as, I'm not even ...

The Law and Business of Open Source Software 2017

On-Demand Web Programs  On-Demand Web Programs    Web Segment  Web Segment    MP3 Audio  Audio Download (MP3)    MP4 - Mobile Video Seg  Video Download (MP4)    

From the program: The Law and Business of Open Source Software 2017

Released on: Nov. 22, 2017

This program will address the critical issues that IP, technology and business lawyers need to consider when handling open source software in today’s economy. Armed with this information, you will be better able to help your clients make intelligent choices and decisions about how to take advantage of the benefits and manage the risks presented by open source software. Lecture Topics [Total time 00:07:15] Segments with an asterisk (*) ...

Patent Litigation 2017

On-Demand Web Programs  On-Demand Web Programs    Web Segment  Web Segment    MP3 Audio  Audio Download (MP3)    MP4 - Mobile Video Seg  Video Download (MP4)    

From the program: Patent Litigation 2017: Advanced Techniques & Best Practices

Released on: Nov. 23, 2017

Whether you are plaintiff’s or defendant’s counsel, you must be up to date on the current state of the law and able to quickly develop successful litigation strategies and tactics. Outside and in-house lawyers with national reputations in patent litigation will offer guidance on trying and managing bench and jury patent trials, as well as U.S. Patent Office post-grant trial proceedings, and the program as a whole will furnish comprehensive ...

New Strategies for Asserting and Defending Against Infringement Claims Involving Acts of Multiple Parties

Transcripts  Transcripts    

Recorded on: Nov. 28, 2017

CHRIS HU: OK. Our next topic is infringement by multiple parties. And our speaker is Rich Martinelli from Orrick. RICHARD F. MARTINELLI: How you doing? All right. Good morning, everyone. As Chris just said, I'm Rich Martinelli. I'm a partner in Orrick's Intellectual Property Business Unit. And I'm going to be talking about situations where to prove infringement you need to show acts of multiple independent parties, and what happens, and what are ...

Ethics in Patent Litigation – Jury Research, Including Use of Social Media

Transcripts  Transcripts    

Recorded on: Nov. 28, 2017

SPEAKER: Thanks. For our last session, it's the ethics session. And this year, the topic is one that we think is very timely. And it's the ethics of social media in jury research. Our speakers are Michael Smith from Siebman, Burg, Phillips & Smith, in the Eastern District of Texas, and Dan Wolfe from DecisionQuest. Who's speaking first? DAN WOLFE: I'm going to go first. SPEAKER: OK, thank you. Thank you for coming. DAN WOLFE: Absolutely. Good afternoon, ...

Strategies for Litigating Patents Concurrently in the District Court and PTAB

Transcripts  Transcripts    

Recorded on: Nov. 28, 2017

SPEAKER 1: OK, welcome back. The next session is on concurrent patent office proceedings. And the speaker is Carol White, Intellectual Property Council for W. L. Gore & Associates in Delaware. Carol. CAROL WHITE: Thank you Chris, and thank you for the opportunity to speak here again at the PLI session. As the in-house counsel at W. L. Gore & Associates, I think we certainly don't maybe have day to day interactions with litigation activities. But ...

Is the Tide Changing Again on the Viability of 101 and 112 as Defenses in Patent Litigation?

Transcripts  Transcripts    

Recorded on: Nov. 28, 2017

CHRISTOPHER K. HU: OK. OK. Welcome back. Before we start with the next presentation, we're bringing Rachel back with some news of a very recent decision today. RACHEL: So it's not very often that there's breaking patent law news. But when we were talking about the venue earlier today, I mentioned that E.D.Va. Found that TC Heartland was not changing intervening law-- other district courts came out the other way. The Federal Circuit today in In re ...

Monetizing Patents – The Changing World of Deriving Benefits from Patents and Portfolios

Transcripts  Transcripts    

Recorded on: Nov. 28, 2017

CHRISTOPHER K. HU: Monetization of patent rights in various ways and the changing landscape. Our panel leader is Eric Lobenfeld from Hogan Lovells. Aaron Bernstein from the Zebra Technologies, Chris Horgan from Roark IP in California, and Katharine Wolanyk from Burford Capital. ERIC J. LOBENFELD: Thanks, Chris. Good afternoon, I'm Eric Lobenfeld. This is the first year we're doing this panel, so it's interesting for us as well. And you're going to ...

The Unwritten Rules: Novel and Creative Strategies and Tactics in Patent Litigation

Transcripts  Transcripts    

Recorded on: Nov. 28, 2017

CHRISTOPHER K. HU: And the next session is sort of the unwritten techniques for successfully handling patent litigation, the stuff they don't teach you in law school. The moderator is my colleague, Charles Monterio, from Blank Rome's Washington office. Cynthia Lambert Hardman from Goodwin Proctor in New York; Margaret Ives from Choate Hall & Stewart in Boston; and my old friend, Andy Schaeffer, from DuPont. CHARLES J. MONTERIO, JR.: Good afternoon. ...

Many Changes Afoot—Continued Rise in Supreme Court Patent Decisions and Other Recent Case Developments and Their Impact

Transcripts  Transcripts    

Recorded on: Nov. 28, 2017

RACHEL HUNNICUTT: All right. I've got my tea, so I will probably be drinking out of it occasionally. I have to apologize. I know I at least sound a lot better that I do. I might be gripping on a little bit to support myself. So if I seem to be faltering, [? May ?] [? Gyves, ?] Chris Hu are going to jump up and grab me. So-- and I'm Rachel Hunnicutt with Wiley Rein. My practice mainly focuses on pharmaceutical litigation. And I also go into FDA counseling ...

Live Demonstration: Delivering an Effective Opening Statement in Patent Cases (Plaintiff v. Defendant)

Transcripts  Transcripts    

Recorded on: Nov. 28, 2017

CHRISTOPHER HU: Welcome back. The next session has been expanded to an hour and a half due to the comments from the audience last year. This is going to be a mock set of openings in a patent case. The moderator of this session will be Dr. Gil Calvillo, a jury researcher among other things, whom I've known for-- I don't know, 20-something years? And then Judge Castillo has graciously agreed to stay to offer his comments on openings, and he will not ...

Making Joint Defense and Indemnity Arrangements Benefit Rather than Hinder Patent Litigation Resolution and Costs

Transcripts  Transcripts    

Recorded on: Nov. 28, 2017

CHRIS: Welcome back. Our last session today is on the issues involving joint defense agreements, and common interest privilege. Our speaker is Jeff Zachmann, litigation counsel at IBM. Jeff. JEFFREY ZACHMANN: Thank you, Chris. Once again this year I find myself as [? Evo ?] says, batting cleanup here. Standing between you, and a tooth crackingly cold iced martini. Preferably shaken, not stirred. My name isn't Bond, but it is Zachmann, so. I'll start ...


  • FOLLOW PLI:
  • twitter
  • LinkedIn
  • YouTube
  • RSS

All Contents Copyright © 1996-2018 Practising Law Institute. Continuing Legal Education since 1933.

© 2018 PLI PRACTISING LAW INSTITUTE. All rights reserved. The PLI logo is a service mark of PLI.